Tag: 上海楼凤SP

Cignal sinks Marinerong Pilipino, punches D-League Finals ticket

first_imgView comments Pamboy Raymundo shot 4-of-7 from rainbow country to wound up with 18 markers, four assists, and three rebounds, Byron Villarias fired 16 points built on three treys, and Jonathan Uyloan dropped 15 markers on a 4-of-8 shooting from beyond the arc as Cignal’s three-point shooting was on point all game long to keep the order despite rallies from Marinero.“We’re happy that we made it to the Finals,” said coach Boyet Fernandez. “It was a tough conference for us. We played seven straight in three weeks, but we’re here and hopefully, we’ll finish it with a championship.”FEATURED STORIESSPORTSEnd of his agony? SC rules in favor of Espinosa, orders promoter heirs to pay boxing legendSPORTSRedemption is sweet for Ginebra, Scottie ThompsonSPORTSMayweather beats Pacquiao, Canelo for ‘Fighter of the Decade’Despite Marinero’s best efforts, it could not break through the eight-point barrier in the second half as the troika of Raymundo, Villarias, and Uyloan all connected from downtown, with the team shooting 11-of-31 from three. That allowed the Hawkeyes to gain a lead as high as 24, 84-60, courtesy of Jose’s freebies in the final 2:19.“It’s about time that we made our three points. We really practiced hard on that. It just came out in this game and I’m really thankful to my players because coach Koy (Banal)’s adjustments were on the spot, but the kick out passes were there and I told them that if they’re open, they should take it and I’m happy that they made their shots,” said Fernandez. Don’t miss out on the latest news and information. Quarters: 22-14, 39-31, 59-48, 87-64.Sports Related Videospowered by AdSparcRead Next PH netball squad gets bamboozled by Thailand Filipinos turn Taal Volcano ash, plastic trash into bricks PLAY LIST 01:40Filipinos turn Taal Volcano ash, plastic trash into bricks01:32Taal Volcano watch: Island fissures steaming, lake water receding02:14Carpio hits red carpet treatment for China Coast Guard02:56NCRPO pledges to donate P3.5 million to victims of Taal eruption00:56Heavy rain brings some relief in Australia02:37Calm moments allow Taal folks some respite Raymar Jose. PBA IMAGESRaymar Jose could not be denied as he steered Cignal HD to a return trip to the championship round with an 87-64 win over Marinerong Pilipino in Game 2 of their 2017 PBA D-League Foundation Cup semifinals series Tuesday at Ynares Sports Arena in Pasig.The SEA Games-bound forward made the most of his time for the Hawkeyes, pouring 24 points and 11 rebounds off the bench to aid his side’s quest for back-to-back titles.ADVERTISEMENT Marcosian mode: Duterte threatens to arrest water execs ‘one night’ Teen gunned down in Masbate 2 nabbed in Bicol drug stings 787 earthquakes recorded in 24 hours due to restive Taal Volcano MOST READ Albay to send off disaster response team to Batangas Ai-Ai delas Alas on Jiro Manio: ‘Sana pinahalagahan niya ang naitulong ko’ LATEST STORIES Vilma Santos, Luis Manzano warn public of fake account posing as her End of his agony? SC rules in favor of Espinosa, orders promoter heirs to pay boxing legend 787 earthquakes recorded in 24 hours due to restive Taal Volcano Cignal now awaits the winner of the Flying V-CEU series for its date in the best-of-three Finals.Robbie Herndon paced Marinerong Pilipino in the losing effort with 17 points and five rebounds, while Jeff Javillonar also got 17 markers and four boards.The Scores:CIGNAL HD 87 – Jose 24, Raymundo 18, Villarias 16, Uyloan 15, Bringas 8, Perkins 4, Cahilig 2, Apinan 0, Arboleda 0, Belencion 0, Sara 0, Sumalinog 0.MARINERONG PILIPINO 64 – Herndon 17, Javillonar 17, Javelona 7, Subido 7, Isip 6, Alabanza 2, Iñigo 2, Lopez 2, Publico 2, Sargent 2, Gabriel 0, Gumaru 0, Marata 0, Moralde 0.ADVERTISEMENTlast_img read more

Vote 360i to Make the Stage at Internet Week 2013

first_imgThe digital habits of Millennials are infinitely different from those of the generations before them – meaning they call for an entirely unique marketing approach.We’ve been continuously exploring and identifying ways to best engage Millennials on behalf of our clients. Most recently, we issued a report last month that tapped into the digital habits of Millennials while in the act of in-store grocery shopping. Among a number of other significant findings, the report noted how 24% of Millennials’ conversations indicated their amusement while in-store – allowing for marketers to make shopping more fun and playful.Now our own Director of Social Marketing Strategy Orli LeWinter is nominated to speak at Internet Week New York’s Main Stage on how marketers can capture the attention of Millennials – when at home or on the go – and also offer up examples of brands doing it right.Vote for Orli’s Marketing to Millennials session.Please note: To vote for the session, you’ll need to register yourself on the Internet Week site. It will only take a moment of your time.Cover Photo via Flickrlast_img read more

Drug companies hold on healthcare slammed

first_imgA research paper published in the European Journal of Clinical Investigation this month claims that patients worldwide are being deceived into taking drugs they don’t need, don’t work and put lives at risk. Co-author of the paper, Dr Emmanuel Stamatakis – Associate Professor at the University of Sydney said it was ”entirely illogical” to rely on the pharmaceutical industry to fund medical research. The Crete-born professor, who is also a senior research associate at University College, London, told Neos Kosmos that whilst industry funding of research was necessary, the model of funding used needs to be radically overhauled. “The current system creates a culture of dependency between the sponsor of the trial, who wants favourable conclusions for their product, and the academic researcher who does the study, who needs funding to advance their career,” said Dr Stamatakis. ”Asking corporate sponsors to conduct pivotal trials on their own products is like asking a painter to judge their own painting to receive an award.” Dr Stamatakis – whose research interests include exploring how too little exercise affects cardiometabolic and mental health – cites as an example of the problem anti-diabetic drugs that increase the risk of heart problems, despite interventions like physical exercise being more effective. The anti-diabetic drug Rosiglitazone continues to be available in Australia despite being withdrawn in Europe and New Zealand after thousands of lawsuits were filed against its manufacturer GlaxoSmithKline. “Rosiglitazone is a good example of the existing regulatory nets being ineffective and slow,” says Stamatakis. “The manufacturer was stockpiling profits and people were dying because of its dangerous side-effects. “The fact that several countries did not even bother to withdraw it from the market shows that there is a reluctance and limited political courage to go against the industry.” The research paper Dr Stamatakis co-wrote – which includes data from studies in the UK and US as well as Australia – says drug companies “masterfully influenced” every stage of the health system. After evaluating 600 clinical trials, researchers found that clinical trials funded by pharmaceutical companies were four times more likely to favour the sponsored drug than drugs sponsored by not-for-profits. The research also showed pharmaceutical companies used flawed evidence of a drug’s effectiveness to persuade doctors to prescribe it. Analysts say Australia is lagging behind other countries in its efforts to limit unethical behaviour by drug companies. In the US, legislation was introduced to allow anyone to look up which doctors receive industry funding. Stamatakis believes one solution would be to ‘blind’ the process of the pharmaceutical industry’s funding of research. “Each company could provide funding to a public pool for clinical research. Then an independent organisation could allocate the funding to research institutions on the basis of their ability and research track record,” says the associate professor. “That way academic institutions and researchers would have no reason to please the sponsor of a trial. A government agency could be the moderator in this process. Such a system could be a major step forward. “Soft steps towards voluntary encouragement will never work. It has to be sorted out with firm legislation – banning direct contact and transactions between doctors and the industry.” A transparency working group has been established by Medicines Australia to identify ways to improve the drug industry’s relationship with Australian healthcare professionals. Its recommendations will be published in June. Rosiglitazone: In July 2011, NPS MEDICINEWISE – an independent not-for-profit which advises Australian health professionals – announced that doctors should contact Medicare for approval of any new or repeat prescription of Rosiglitazone and advised avoiding its prescription to anyone with a risk of cardiovascular problems. Facebook Twitter: @NeosKosmos Instagramlast_img read more